Text from here

Information

Back issues
Challenge to crowdfunding!
【Press release】"Nanomachines that carry nucleic acid medicine for fundamental treatment of hereditary intractable disease. Launched crowdfunding for R&D and disease enlightenment."
・Start research and development of nucleic acid medicines that lead to fundamental treatment of designated intractable disease "cystic fibrosis".
・Start recruitment of crowdfunding in partnership with Academia Mist.
・The recruitment period is between June 28-August 26. The target amount is ¥ 400,000.
・Expect to connect not only to raising research funding but also to social enlightenment of “cystic fibrosis”.
Press release text

Cystic fibrosis is a rare disease that occurs at a rate of 1 in 600,000 people in Japan, and highly viscous secretions are excessively secreted in major organs throughout the body, such as the lungs and the pancreas. It is a disease that causes various pains such as dyspnea and digestive disorders.
Currently, there is no drug effective for the fundamental treatment, and it is classified as a designated intractable disease by the Ministry of Health, Labor and Welfare.
Your support is very much appreciated.
Please click here for details.
7.15.2019
【Report】An interview article by Kataoka (Director General of iCONM, Professor, The University of Tokyo) has been published in the magazine Pharmaceutical Economics. It describes the background that Dr. Kataoka has spent and the elements that are necessary for a successful medical-industrial collaboration.
  • From DDS to "In Body Hospitals" Practitioner of medical-industrial collaboration 2 Kazunori Kataoka Director, Center for Nanomedical Innovation.
7.4.2019
【Press release】Tokyo Medical and Dental Universiy has made a press release that a manuscript "Enhancement of Motor Function Recovery After Spinal Cord Injury in Mice by Delivery of Brain Derived Neurotrophic Factor mRNA" by Dr. Keiji Itaka, COINS theme 3 leader, Professor, Tokyo Medial and Dental University, et al. has been published online in "Molecular Therapy-Nucleic Acids" on June 28, 2019.
Press release text
6.25.2019
【Activity Report】June 25th (Tue.), COINS Seminar #45 was held at iCONM.
Speaker: Dr. Makoto Miyagishi
Group Leader, Molecular Composite Medicine Research Group,
Biomedical Research Institute, Advanced Industrial Science and Technology (AIST)
Title: " Development of screening method of nucleic acid aptamer, and its application to finding of DNA/RNA catalyst"
Click here for details
6.24.2019
【Report】Announcing a new choice of startup support program "J-Startup" by public and private!
The Ministry of Economy, Trade and Industry has newly identified 49 companies as startup support companies and announced their press.
COINS's venture company Brazon Therapeutics is among the 49 companies.
About the selection of "J-Startup 2019" | Ministry of Economy, Trade and Industry
6.14.2019
【Activity Report】12th COINS General meeting was held on 14th June.
Related page is here.
6.5.2019
【News Coverage】Research Leader, Kazunori Kataoka (Director General of
iCONM, Professor, The University of Tokyo) gave a talk at Link-J Networking Reception UCLA Health : Partnering with Industry to Advance Healthcare that held on 5/16. He talked about the academic exchange with UCLA that lasts for more than a decade.
6.3.2019
【Report】AccuRna, Inc. one of the participating institutions announced that they will start
clinical trials for breast cancer treatment with SiRNA based nucleic acid medicines later this year.
5.31.2019
【Award】 Takuya Nishizono (The University of Tokyo) received the Polymer Society of Japan Excellent Poster Award at the 68th SPSJ Annual Meeting Best poster award.
  • Title:Evaluation on brain accumulation and distribution of nanocarriers with different sizes
5.31.2019
【Award】 Yoshihiro Tachihara (The University of Tokyo) received the Polymer Society of Japan Excellent Poster Award at the 68th SPSJ Annual Meeting Best poster award.
  • Title:Development of pH-Sensitive Polymeric Micelles for Targeted Delivery of the Macrocycle Valinomycin via Host Guest Interaction
5.30.2019
【Information】Professor Kazunori Kataoka, Research Leader of COINS, was installed as an Honorary Member of the Society of Polymer Science, Japan.
5.24.2019
【Information】We will hold the COINS Seminar #45 at iCONM.
June 25th (Tue.) 16:00–17:15 (Research Mixer 17:15~18:15 *JPY500)

Speaker: Dr. Makoto Miyagishi
Group Leader, Molecular Composite Medicine Research Group, Biomedical Research Institute, Advanced Industrial Science and Technology (AIST).

Title: Development of screening method of nucleic acid aptamer, and its application to finding of DNA/RNA catalyst

Venue: Innovation Center of NanoMedicine (iCONM) 3F 3001 Access

Click here for details
*Registration is now closed.
5.14.2019
【Activity Report】May 14th (Tue.), COINS Seminar #44 was held at iCONM.
Speaker: Dr. Hiroyuki Fujita
Professor, Tokyo City University, Advanced Research Lab.
Title: "MEMS Technology and Applications to Biomedical Field"
Click here for details
4.26.2019
【TV】Research Leader, Kazunori Kataoka (Director General of iCONM, Professor, The University of Tokyo) is going to appear on TV program!
  • 29 April 8:00-10:30 AM Nippon Televison 『Sukkiri』
4.26.2019
【TV】Research Promotion Leader of COINS, Mr. Hirokazu Iwasaki is going to appear on TV program tomorrow!
  • 26 April 6:00PM TVK 『NEWS Harbor』
4.23.2019
【Press Release】We held a press conference by Kazunori KATAOKA(Director General, iCONM / Professor, The of Tokyo)and Kanjiro MIYATA, COINS Theme 1 leader(Associate Professor, The University of Tokyo / Visiting Scientist, iCONM). They succeeded in developing the Nucleic Acid Medicine-loaded Nanomachine, a technology that can stably protect nucleic acid drugs that are prone to deactivation in the bloodstream and deliver them to intractable cancers such as pancreatic cancer and brain tumors.
Click here for details.

This research result was published in "Nature Communications (UK scientific journal)" on Wednessday, April 24, 2019.

The articles regarding this matter were introduced on some newspapers.
Click here for more details of the press conference.
The list of media coverage
4.16.2019
【Activity Report】COINS Seminar #43 was held at Kawasaki King Skyfront Tokyu REI Hotel.
Part1
Speaker: Mr. Kazuomi Iwatani
Manager, Intellectual Property Division
Japan Agency for Medical Research and Development(AMED)
Title: "The briefing session of support program by Intellectual Property Division of AMED"

Part2
Speaker: Dr. Hiroatsu Nohara
Associated Researcher, Affiliation: Lest-CNRS / Aix-Marseille University
Title: "French medical cluster: the case of “Oncopole” in Toulouse"
Click here for details
4.14.2019
【Information】We will hold the COINS Seminar #44 at iCONM.
May 14th (Tue.) 16:00–17:15 (Research Mixer 17:15-18:15 *JPY500)
Speaker: Dr. Hiroyuki Fujita
Professor, Tokyo City University, Advanced Research Lab.
Title: MEMS Technology and Applications to Biomedical Field

Venue: Venue: Innovation Center of NanoMedicine (iCONM) 3F 3001 Access
Click here for details
*Registration is now closed.
4.9.2019
【Award】Dr. Nobuhiro Nishiyama, Leader of Theme 5 (Professor, Institute of Innovative Research, Tokyo Institute of Technology / Principal Research Scientist / Laboratory Head, KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION Innovation Center of NanoMedicine(iCONM)) was awarded The Prize for Science and Technology (Research Category) for The Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology.
His research title was “Study on development and medical application of nanomachines based on polymer design".
4.3.2019
【Information】COINS SDGs promotion video has been completed. This is request from JST.
We are proactively contributing to the achievement of the SDGs goal 3 of "Good health and well-being". We hope you enjoy it!
4.1.2019
【News Coverage】Research Leader, Kazunori Kataoka (Director General of iCONM, Professor, The University of Tokyo) interview was introduced on THEMIS magazine (1 April).
  • Dr. Kazunori Kataoka, Director-General, Innovation Center of NanoMedicine faces the challenge to eliminate cancer and Alzheimer's disease with polymer micelle

About COINS

COINS (Center of Open Innovation Network for Smart Health) is a research center of an entirely new idea for developing "products and services that changes the future" by anticipating social needs in the future and integrating cutting-edge technologies, human resources and ideas from universities and private companies in and outside Japan.

COINS is an initiative under the Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI STREAM) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.

Page Top